Article (Périodiques scientifiques)
Validation of a Parkinson's disease questionnaire-39-based functional mobility composite score (FMCS) in people with Parkinson's disease.
HANFF, Anne-Marie; McCrum, Christopher; RAUSCHENBERGER, Armin et al.
2023In Parkinsonism and Related Disorders, 112, p. 105442
Peer reviewed vérifié par ORBi
 

Documents


Texte intégral
PIIS1353802023001657.pdf
Postprint Éditeur (2.03 MB)
Télécharger
Annexes
Supplementary_Material.pdf
(534.21 kB)
Télécharger

Tous les documents dans ORBilu sont protégés par une licence d'utilisation.

Envoyer vers



Détails



Mots-clés :
Construct validity; Dimensional measurement accuracy; Functional status; Neurodegenerative diseases; PDQ-39; Psychometrics; Self-care; Social participation
Résumé :
[en] INTRODUCTION: Functional mobility is an important outcome for people with Parkinson's disease (PwP). Despite this, there is no established patient-reported outcome measure that serves as a gold standard for assessing patient-reported functional mobility in PwP. We aimed to validate the algorithm calculating the Parkinson's Disease Questionnaire-39 (PDQ-39) based Functional Mobility Composite Score (FMCS). METHODS: We designed a count-based algorithm to measure patient-reported functional mobility in PwP from items of the PDQ-39 subscales mobility and activities of daily living. Convergent validity of the algorithm calculating the PDQ-39-based FMCS was assessed using the objective Timed Up and Go (n = 253) and discriminative validity was assessed by comparing the FMCS with patient-reported (MDS-UPDRS II) and clinician-assessed (MDS-UPDRS III) motor symptoms as well as between disease stages (H&Y) and PIGD phenotypes (n = 736). Participants were between 22 and 92 years old, with a disease duration from 0 to 32 years and 64.9% in a H&Y 1-2 ranging from 1 to 5. RESULTS: Spearman correlation coefficients (r(s)) ranging from -0.45 to -0.77 (p < 0.001) indicated convergent validity. Hence, a t-test suggested sufficient ability of the FMCS to discriminate (p < 0.001) between patient-reported and clinician-assessed motor symptoms. More specifically, FMCS was more strongly associated with patient-reported MDS-UPDRS II (r(s) = -0.77) than clinician-reported MDS-UPDRS III (r(s) = -0.45) and can discriminate between disease stages as between PIGD phenotypes (p < 0.001). CONCLUSION: The FMCS is a valid composite score to assess functional mobility through patient reports in PwP for studying functional mobility in studies using the PDQ-39.
Disciplines :
Neurologie
Auteur, co-auteur :
HANFF, Anne-Marie  ;  University of Luxembourg > Faculty of Science, Technology and Medecine (FSTM)
McCrum, Christopher
RAUSCHENBERGER, Armin ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Biomedical Data Science
Aguayo, Gloria A.
Zeegers, Maurice P.
LEIST, Anja  ;  University of Luxembourg > Faculty of Humanities, Education and Social Sciences (FHSE) > Department of Social Sciences (DSOC)
KRÜGER, Rejko ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Translational Neuroscience
Co-auteurs externes :
yes
Langue du document :
Anglais
Titre :
Validation of a Parkinson's disease questionnaire-39-based functional mobility composite score (FMCS) in people with Parkinson's disease.
Date de publication/diffusion :
2023
Titre du périodique :
Parkinsonism and Related Disorders
ISSN :
1353-8020
eISSN :
1873-5126
Volume/Tome :
112
Pagination :
105442
Peer reviewed :
Peer reviewed vérifié par ORBi
Projet FnR :
FNR11264123 - Ncer-pd, 2015 (01/01/2015-30/11/2020) - Rejko Krüger
Commentaire :
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Disponible sur ORBilu :
depuis le 16 juillet 2023

Statistiques


Nombre de vues
185 (dont 4 Unilu)
Nombre de téléchargements
107 (dont 4 Unilu)

citations Scopus®
 
3
citations Scopus®
sans auto-citations
2
citations OpenAlex
 
5

Bibliographie


Publications similaires



Contacter ORBilu